drugset / Trial / NCT01555476

Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores

NCT01555476

Phase 1 Completed 32 enrolled McNeil AB
RandomizedCrossoverOpen-labelBasic science

Summary

This study is designed to assess bioequivalence between one test and one reference formulation used for temporary relief of pain. The results will help decide if the new medicine is likely to provide pain relief similar to the product being sold.

Timeline

Start
2012-02
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 200 mg Oral

Indications

No indication recorded.